Investor's Business Daily on MSN
Biogen clears key benchmark, hitting 80-plus RS rating
Rating for BiogenBIIB jumped into a new percentile Monday, with an increase from 80 to 84.Please watch the video at Investors ...
(BIIB) announced an update on their ongoing clinical study.Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you ...
Here are the top catalysts for the Nasdaq 100 Index and its ETFs, like QQQ and JEPQ, including the upcoming BoJ rate decision ...
Six companies, including Alnylam Pharmaceuticals and Seagate Technology, will join the Nasdaq 100 when the changes take effect later this month. The updates aim to keep the index aligned with the ...
Tolebrutinib was one of three oral BTK inhibitors that Sanofi acquired as part of its $3.7 billion buyout of Principia ...
With notable therapies from Biogen, Sarepta and MacroGenics failing to show efficacy in pivotal or confirmatory trials, experts question the use of biomarker evidence for approval while one former ...
Determining which patients should receive the treatment will still require individual risk-benefit assessments, experts say.
Friday’s Nasdaq 100 reconstitution was a white-knuckle moment for Strategy shareholders. The annual review, which reshuffles the index to reflect the largest non-financial companies on the exchange, ...
We found that one-third of pharmaceutical companies proactively released the launch price of their medications between 2022 and 2024, and another third released them reactively. Smaller public ...
In this video, Brian T. Hill, MD, PhD, discusses a study presented at ASH Annual Meeting and Exposition which assessed a triplet nonchemotherapy regimen in older and medically unfit patients with ...
Manifold Bio, a platform therapeutics company pioneering AI-guided drug discovery coupled with massively multiplexed in vivo measurement, today announced the expansion of its executive leadership team ...
Western Digital Corp. (NASDAQ:WDC) stock rose 1.7% Monday following the announcement of its inclusion in the Nasdaq-100 Index as part of the annual reconstitution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results